Biogen | BIIB - PE Price to Earnings


Biogen reported $9.38 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
ALKERMES USD 14.9 1.11 Sep/2025
Amgen USD 9.49 3.02 Sep/2025
Bayer EUR 5.93 0.68 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
Incyte USD 17.63 2.86 Sep/2025
Merck USD 8.84 0.26 Sep/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
PTC Therapeutics USD 6.73 0.26 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Sanofi EUR 15.75 1.53 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Teva Pharmaceutical Industries USD 10.11 1.04 Dec/2025
United Therapeutics USD 15.7 4.24 Sep/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025